Thermo Fisher (TMO) Scientific announced that its Board of Directors has authorized the repurchase of $5B of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher’s Strategic Acquisition of Clario: Enhancing Clinical Trial Offerings and Driving Earnings Growth
- Thermo Fisher’s Strategic Acquisition of Clario: A Buy Rating with Promising Financial and Growth Prospects
- Thermo Fisher price target raised to $610 from $580 at Argus
- Thermo Fisher Announces Acquisition of Clario Holdings
- Thermo Fisher to acquire Clario Holdings for $8.875B in cash at close